Known targets — ChEMBL curated mechanism
ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.60 |
| ▸ | CHRM2 known ✓ | P08172 | 6/20 | 0.46 |
| ▸ | CHRM3 known ✓ | P20309 | 6/20 | 0.46 |
| ▸ | KCNH2 known ✓ | Q12809 | 2/20 | 0.43 |
| ▸ | HTR2C known ✓ | P28335 | 3/20 | 0.43 |
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.43 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A known ✓ | Q03164 | 1/20 | 0.43 |
| ▸ | DRD2 known ✓ | P14416 | 1/20 | 0.42 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.42 |
| ▸ | SLC6A4 known ✓ | P31645 | 1/20 | 0.42 |
| ▸ | HTR2B known ✓ | P41595 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.60 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.48 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.48 |
| ▸ | HTR3B | O95264 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | HTR3A | P46098 | 1/20 | 0.48 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.48 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL970050 | 0.90 | SLC6A2 (0.74) | SLC6A2SLC6A3OPRK1HTR3EHTR3B | |
| Fumaric Acid SCHEMBL1178478 | 0.87 | SLC6A2 (0.55) | SLC6A2SLC6A3OPRK1CHRM2CHRM1 | |
| Fumaric Acid SCHEMBL971277 | 0.85 | ACACB (0.47) | SLC6A2SLC6A3OPRK1HTR3EHTR3B | |
| Fumaric Acid SCHEMBL1178501 | 0.84 | SLC6A2 (0.60) | SLC6A2SLC6A3OPRK1HTR3EHTR3B | |
| Fumaric Acid SCHEMBL1178130 | 0.84 | SLC6A2 (0.60) | SLC6A2SLC6A3OPRK1HTR3EHTR3B | |
| Fumaric Acid SCHEMBL1178204 | 0.80 | OPRK1 (0.50) | SLC6A2SLC6A3OPRK1HTR3EHTR3B | |
| Fumaric Acid SCHEMBL1177690 | 0.80 | SLC6A2 (0.55) | SLC6A2SLC6A3OPRK1HTR3EHTR3B | |
| SCHEMBL12917614 | 0.79 | SLC6A2 (0.64) | SLC6A2SLC6A3OPRK1CHRM2CHRM1 | |
| SCHEMBL1164680 | 0.77 | SLC6A2 (1.00) | SLC6A2SLC6A3OPRK1HTR3EHTR3B | |
| SCHEMBL1164678 | 0.77 | SLC6A2 (1.00) | SLC6A2SLC6A3OPRK1HTR3EHTR3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015235-A1 | NOVEL PHENYLETHYNYL DERIVATIVES OF 8-AZA-BICYCLO[3.2.1]OCTANE AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS | NEUROSEARCH A/S | 2011-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015235-A1 | NOVEL PHENYLETHYNYL DERIVATIVES OF 8-AZA-BICYCLO[3.2.1]OCTANE AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS | SLC18A2, SLC18A3, SLC6A2 | SLC6A2 3/4885CHRM2 332/4885CHRM3 436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.